白川康太郎

Last Update: 2019/06/21 18:19:36

Name(Kanji/Kana/Abecedarium Latinum)

白川康太郎/シラカワコウタロウ/Sirakawa, Kotaro

Primary Affiliation(Org1/Job title)

Kyoto University Hospital/Assistant Professor

Academic Degree

Field(Japanese)	Field(English)	University(Japanese)	University(English)	Method
博士（医学）		京都大学

researchmap URL

https://researchmap.jp/7000009493

Research Topics

(Japanese)
HIV-1感染症/AIDSおよびリンパ系造血器腫瘍の発症機序と新規治療法の開発に関する研究
(English)
Molecular pathogenesis and novel treatment strategy for HIV-1/AIDS and lymphoid malignancies

Overview of the research

(Japanese)
当研究室は1) HIV-1の潜伏感染のメカニズムとそれを標的とした治療法の開発、2) シトシン脱アミノ化酵素APOBEC3によるゲノム変異と癌発症のメカニズムの解析、3)リンパ系造血器腫瘍におけるヒストン脱アセチル化酵素、ヒストンアセチル化酵素の役割についての基礎研究と臨床応用に関する研究を行っています。
(English)
Our research focuses on 1) molecular mechanisms of HIV-1 latency, 2) genomic mutation and cancer development by cytidine deaminase APOBEC3, 3) roles of reversible lysine acetylation in lymphoid malignancy.

Fields of research (key words)

Key words(Japanese)	Key words(English)
シトシン脱アミノ化酵素	cytidine deaminase
ヒストン脱アセチル化酵素	histone deacetylase
ヒストンアセチル化酵素	histone acetyltransferase
HIV-1/AIDS	HIV-1/AIDS
悪性リンパ腫	malignant lymphoma

Published Papers

Author	Author(Japanese)	Author(English)	Title	Title(Japanese)	Title(English)	Bibliography	Bibliography(Japanese)	Bibliography(English)	Publication date	Refereed paper	Language	Publishing type	Disclose
Matsumoto T, Shirakawa K, Yokoyama M, Fukuda H, Sarca AD, Koyabu S, Yamazaki H, Kazuma Y, Matsui H, Maruyama W, Nagata K, Tanabe F, Kobayashi M, Shindo K, Morishita R, Sato H, Takaori-Kondo A.	Matsumoto T, Shirakawa K, Yokoyama M, Fukuda H, Sarca AD, Koyabu S, Yamazaki H, Kazuma Y, Matsui H, Maruyama W, Nagata K, Tanabe F, Kobayashi M, Shindo K, Morishita R, Sato H, Takaori-Kondo A.	Matsumoto T, Shirakawa K, Yokoyama M, Fukuda H, Sarca AD, Koyabu S, Yamazaki H, Kazuma Y, Matsui H, Maruyama W, Nagata K, Tanabe F, Kobayashi M, Shindo K, Morishita R, Sato H, Takaori-Kondo A.	Protein kinase A inhibits tumor mutator APOBEC3B through phosphorylation.	Protein kinase A inhibits tumor mutator APOBEC3B through phosphorylation.	Protein kinase A inhibits tumor mutator APOBEC3B through phosphorylation.	Sci Rep.	Sci Rep.	Sci Rep.	2019/06	Refereed	English	Research paper(scientific journal)	Disclose to all
Yamazaki H, Shirakawa K, Matsumoto T, Hirabayashi S, Murakawa Y, Kobayashi M, Sarca AD, Kazuma Y, Matsui H, Maruyama W, Fukuda H, Shirakawa R, Shindo K, Ri M, Iida S, Takaori-Kondo A.	Yamazaki H, Shirakawa K, Matsumoto T, Hirabayashi S, Murakawa Y, Kobayashi M, Sarca AD, Kazuma Y, Matsui H, Maruyama W, Fukuda H, Shirakawa R, Shindo K, Ri M, Iida S, Takaori-Kondo A.	Yamazaki H, Shirakawa K, Matsumoto T, Hirabayashi S, Murakawa Y, Kobayashi M, Sarca AD, Kazuma Y, Matsui H, Maruyama W, Fukuda H, Shirakawa R, Shindo K, Ri M, Iida S, Takaori-Kondo A.	Endogenous APOBEC3B Overexpression Constitutively Generates DNA Substitutions and Deletions in Myeloma Cells.	Endogenous APOBEC3B Overexpression Constitutively Generates DNA Substitutions and Deletions in Myeloma Cells.	Endogenous APOBEC3B Overexpression Constitutively Generates DNA Substitutions and Deletions in Myeloma Cells.	Sci Rep., doi: 10.1038/s41598-019-43575-	Sci Rep., doi: 10.1038/s41598-019-43575-	Sci Rep., doi: 10.1038/s41598-019-43575-	2019/05	Refereed	English	Research paper(scientific journal)	Disclose to all
Fukuda H, Li S, Sardo L, Smith JL, Yamashita K, Sarca AD, Shirakawa K, Standley DM, Takaori-Kondo A, Izumi T.	Fukuda H, Li S, Sardo L, Smith JL, Yamashita K, Sarca AD, Shirakawa K, Standley DM, Takaori-Kondo A, Izumi T.	Fukuda H, Li S, Sardo L, Smith JL, Yamashita K, Sarca AD, Shirakawa K, Standley DM, Takaori-Kondo A, Izumi T.	Structural Determinants of the APOBEC3G N-Terminal Domain for HIV-1 RNA Association.	Structural Determinants of the APOBEC3G N-Terminal Domain for HIV-1 RNA Association.	Structural Determinants of the APOBEC3G N-Terminal Domain for HIV-1 RNA Association.	Front Cell Infect Microbiol.	Front Cell Infect Microbiol.	Front Cell Infect Microbiol.	2019/05	Refereed	English	Research paper(scientific journal)	Disclose to all
Yoshinaga N, Shindo K, Matsui Y, Takiuchi Y, Fukuda H, Nagata K, Shirakawa K, Kobayashi M, Takeda S, Takaori-Kondo A.	Yoshinaga N, Shindo K, Matsui Y, Takiuchi Y, Fukuda H, Nagata K, Shirakawa K, Kobayashi M, Takeda S, Takaori-Kondo A.	Yoshinaga N, Shindo K, Matsui Y, Takiuchi Y, Fukuda H, Nagata K, Shirakawa K, Kobayashi M, Takeda S, Takaori-Kondo A.	A screening for DNA damage response molecules that affect HIV-1 infection.	A screening for DNA damage response molecules that affect HIV-1 infection.	A screening for DNA damage response molecules that affect HIV-1 infection.	Biochem Biophys Res Commun., 21, 513, 93-98	Biochem Biophys Res Commun., 21, 513, 93-98	Biochem Biophys Res Commun., 21, 513, 93-98	2019/05	Refereed	English	Research paper(scientific journal)	Disclose to all
Eso Y, Uza N, Shirakawa K, Sawada K, Katsuragi K, Matsuura M, Seno H.	Eso Y, Uza N, Shirakawa K, Sawada K, Katsuragi K, Matsuura M, Seno H.	Eso Y, Uza N, Shirakawa K, Sawada K, Katsuragi K, Matsuura M, Seno H.	Choledochoduodenal Fistula during Chemotherapy with Brentuximab Vedotin for Methotrexate-associated Lymphoproliferative Disorder.	Choledochoduodenal Fistula during Chemotherapy with Brentuximab Vedotin for Methotrexate-associated Lymphoproliferative Disorder.	Choledochoduodenal Fistula during Chemotherapy with Brentuximab Vedotin for Methotrexate-associated Lymphoproliferative Disorder.	Intern Med.	Intern Med.	Intern Med.	2018/05	Refereed	English	Research paper(scientific journal)	Disclose to all
Kawata T, Tada K, Kobayashi M, Sakamoto T, Takiuchi Y, Iwai F, Sakurada M, Hishizawa M, Shirakawa K, Shindo K, Sato H, Takaori-Kondo A.	Kawata T, Tada K, Kobayashi M, Sakamoto T, Takiuchi Y, Iwai F, Sakurada M, Hishizawa M, Shirakawa K, Shindo K, Sato H, Takaori-Kondo A.	Kawata T, Tada K, Kobayashi M, Sakamoto T, Takiuchi Y, Iwai F, Sakurada M, Hishizawa M, Shirakawa K, Shindo K, Sato H, Takaori-Kondo A.	Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T-cell leukemia.	Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T-cell leukemia.	Dual inhibition of the mTORC1 and mTORC2 signaling pathways is a promising therapeutic target for adult T-cell leukemia.	Cancer Sci., 109, 1, 103-111	Cancer Sci., 109, 1, 103-111	Cancer Sci., 109, 1, 103-111	2018/01	Refereed	English	Research paper(scientific journal)	Disclose to all
Takiuchi Y, Kobayashi M, Tada K, Iwai F, Sakurada M, Hirabayashi S, Nagata K, Shirakawa K, Shindo K, Yasunaga JI, Murakawa Y, Rajapakse V, Pommier Y, Matsuoka M, Takaori-Kondo A.	Takiuchi Y, Kobayashi M, Tada K, Iwai F, Sakurada M, Hirabayashi S, Nagata K, Shirakawa K, Shindo K, Yasunaga JI, Murakawa Y, Rajapakse V, Pommier Y, Matsuoka M, Takaori-Kondo A.	Takiuchi Y, Kobayashi M, Tada K, Iwai F, Sakurada M, Hirabayashi S, Nagata K, Shirakawa K, Shindo K, Yasunaga JI, Murakawa Y, Rajapakse V, Pommier Y, Matsuoka M, Takaori-Kondo A.	HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia.	HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia.	HTLV-1 bZIP factor suppresses TDP1 expression through inhibition of NRF-1 in adult T-cell leukemia.	Sci Rep., 7, 1, 12849	Sci Rep., 7, 1, 12849	Sci Rep., 7, 1, 12849	2017/10	Refereed	English		Disclose to all
Matsui Y, Shindo K, Nagata K, Yoshinaga N, Shirakawa K, Kobayashi M, Takaori-Kondo A	Matsui Y, Shindo K, Nagata K, Yoshinaga N, Shirakawa K, Kobayashi M, Takaori-Kondo A	Matsui Y, Shindo K, Nagata K, Yoshinaga N, Shirakawa K, Kobayashi M, Takaori-Kondo A	Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.	Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.	Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.	The Journal of biological chemistry, 291, 48, 24892-24899	The Journal of biological chemistry, 291, 48, 24892-24899	The Journal of biological chemistry, 291, 48, 24892-24899	2016/11	Refereed			Disclose to all
Kishimoto W, Nishikori M, Arima H, Miyoshi H, Sasaki Y, Kitawaki T, Shirakawa K, Kato T, Imaizumi Y, Ishikawa T, Ohno H, Haga H, Ohshima K, Takaori-Kondo A	Kishimoto W, Nishikori M, Arima H, Miyoshi H, Sasaki Y, Kitawaki T, Shirakawa K, Kato T, Imaizumi Y, Ishikawa T, Ohno H, Haga H, Ohshima K, Takaori-Kondo A	Kishimoto W, Nishikori M, Arima H, Miyoshi H, Sasaki Y, Kitawaki T, Shirakawa K, Kato T, Imaizumi Y, Ishikawa T, Ohno H, Haga H, Ohshima K, Takaori-Kondo A	Expression of Tim-1 in primary CNS lymphoma.	Expression of Tim-1 in primary CNS lymphoma.	Expression of Tim-1 in primary CNS lymphoma.	Cancer medicine, 5, 11, 3235-3245	Cancer medicine, 5, 11, 3235-3245	Cancer medicine, 5, 11, 3235-3245	2016/11	Refereed			Disclose to all
Maruyama W, Shirakawa K, Matsui H, Matsumoto T, Yamazaki H, Sarca AD, Kazuma Y, Kobayashi M, Shindo K, Takaori-Kondo A	Maruyama W, Shirakawa K, Matsui H, Matsumoto T, Yamazaki H, Sarca AD, Kazuma Y, Kobayashi M, Shindo K, Takaori-Kondo A	Maruyama W, Shirakawa K, Matsui H, Matsumoto T, Yamazaki H, Sarca AD, Kazuma Y, Kobayashi M, Shindo K, Takaori-Kondo A	Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells.	Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells.	Classical NF-κB pathway is responsible for APOBEC3B expression in cancer cells.	Biochemical and biophysical research communications, 478, 3, 1466-1471	Biochemical and biophysical research communications, 478, 3, 1466-1471	Biochemical and biophysical research communications, 478, 3, 1466-1471	2016/09	Refereed			Disclose to all
Shirakawa K, Wang L, Man N, Maksimoska J, Sorum AW, Lim HW, Lee IS, Shimazu T, Newman JC, Schröder S, Ott M, Marmorstein R, Meier J, Nimer S, Verdin E.	Shirakawa K, Wang L, Man N, Maksimoska J, Sorum AW, Lim HW, Lee IS, Shimazu T, Newman JC, Schröder S, Ott M, Marmorstein R, Meier J, Nimer S, Verdin E.	Shirakawa K, Wang L, Man N, Maksimoska J, Sorum AW, Lim HW, Lee IS, Shimazu T, Newman JC, Schröder S, Ott M, Marmorstein R, Meier J, Nimer S, Verdin E.	Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity.	Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity.	Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity.	Elife., 31, 5, e11156	Elife., 31, 5, e11156	Elife., 31, 5, e11156	2016/05	Refereed	English		Disclose to all
Wiley CD, Velarde MC, Lecot P, Liu S, Sarnoski EA, Freund A, Shirakawa K, Lim HW, Davis SS, Ramanathan A, Gerencser AA, Verdin E, Campisi J.	白川康太郎Wiley CD, Velarde MC, Lecot P, Liu S, Sarnoski EA, Freund A, Shirakawa K, Lim HW, Davis SS, Ramanathan A, Gerencser AA, Verdin E, Campisi J.	Wiley CD, Velarde MC, Lecot P, Liu S, Sarnoski EA, Freund A, Shirakawa K, Lim HW, Davis SS, Ramanathan A, Gerencser AA, Verdin E, Campisi J.	Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype.	Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype.	Mitochondrial Dysfunction Induces Senescence with a Distinct Secretory Phenotype.	Cell Metab., 9, 23, 303-314	Cell Metab., 9, 23, 303-314	Cell Metab., 9, 23, 303-314	2016/02	Refereed	English	Research paper(scientific journal)	Disclose to all
Min SW, Chen X, Tracy TE, Li Y, Zhou Y, Wang C, Shirakawa K, Minami SS, Defensor E, Mok SA, Sohn PD, Schilling B, Cong X, Ellerby L, Gibson BW, Johnson J, Krogan N, Shamloo M, Gestwicki J, Masliah E, Verdin E, Gan L.	Min SW, Chen X, Tracy TE, Li Y, Zhou Y, Wang C, Shirakawa K, Minami SS, Defensor E, Mok SA, Sohn PD, Schilling B, Cong X, Ellerby L, Gibson BW, Johnson J, Krogan N, Shamloo M, Gestwicki J, Masliah E, Verdin E, Gan L.	Min SW, Chen X, Tracy TE, Li Y, Zhou Y, Wang C, Shirakawa K, Minami SS, Defensor E, Mok SA, Sohn PD, Schilling B, Cong X, Ellerby L, Gibson BW, Johnson J, Krogan N, Shamloo M, Gestwicki J, Masliah E, Verdin E, Gan L.	Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits.	Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits.	Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits.	Nat Med., 21, 10, 1154-1162	Nat Med., 21, 10, 1154-1162	Nat Med., 21, 10, 1154-1162	2015/10	Refereed	English	Research paper(scientific journal)	Disclose to all
Lim HW, Kang SG, Ryu JK, Schilling B, Fei M, Lee IS, Kehasse A, Shirakawa K, Yokoyama M, Schnölzer M, Kasler HG, Kwon HS, Gibson BW, Sato H, Akassoglou K, Xiao C, Littman DR, Ott M, Verdin E	Lim HW, Kang SG, Ryu JK, Schilling B, Fei M, Lee IS, Kehasse A, Shirakawa K, Yokoyama M, Schnölzer M, Kasler HG, Kwon HS, Gibson BW, Sato H, Akassoglou K, Xiao C, Littman DR, Ott M, Verdin E	Lim HW, Kang SG, Ryu JK, Schilling B, Fei M, Lee IS, Kehasse A, Shirakawa K, Yokoyama M, Schnölzer M, Kasler HG, Kwon HS, Gibson BW, Sato H, Akassoglou K, Xiao C, Littman DR, Ott M, Verdin E	SIRT1 deacetylates RORγt and enhances Th17 cell generation.	SIRT1 deacetylates RORγt and enhances Th17 cell generation.	SIRT1 deacetylates RORγt and enhances Th17 cell generation.	The Journal of experimental medicine, 212, 5, 607-617	The Journal of experimental medicine, 212, 5, 607-617	The Journal of experimental medicine, 212, 5, 607-617	2015/05	Refereed			Disclose to all
Tada K, Kobayashi M, Takiuchi Y, Iwai F, Sakamoto T, Nagata K, Shinohara M, Io K, Shirakawa K, Hishizawa M, Shindo K, Kadowaki N, Hirota K, Yamamoto J, Iwai S, Sasanuma H, Takeda S, Takaori-Kondo A.	Tada K, Kobayashi M, Takiuchi Y, Iwai F, Sakamoto T, Nagata K, Shinohara M, Io K, Shirakawa K, Hishizawa M, Shindo K, Kadowaki N, Hirota K, Yamamoto J, Iwai S, Sasanuma H, Takeda S, Takaori-Kondo A.	Tada K, Kobayashi M, Takiuchi Y, Iwai F, Sakamoto T, Nagata K, Shinohara M, Io K, Shirakawa K, Hishizawa M, Shindo K, Kadowaki N, Hirota K, Yamamoto J, Iwai S, Sasanuma H, Takeda S, Takaori-Kondo A.	Abacavir, an anti-HIV-1 drug, targets TDP1-deficient adult T cell leukemia.	Abacavir, an anti-HIV-1 drug, targets TDP1-deficient adult T cell leukemia.	Abacavir, an anti-HIV-1 drug, targets TDP1-deficient adult T cell leukemia.	Sci Adv., 24, 1, e1400203.	Sci Adv., 24, 1, e1400203.	Sci Adv., 24, 1, e1400203.	2015/04	Refereed	English	Research paper(scientific journal)	Disclose to all
Yamazaki H, Kondo T, Tatsumi G, Kotani S, Arai Y, Shirakawa K, Kitano T, Hishizawa M, Kadowaki N, Takaori-Kondo A	Yamazaki H, Kondo T, Tatsumi G, Kotani S, Arai Y, Shirakawa K, Kitano T, Hishizawa M, Kadowaki N, Takaori-Kondo A	Yamazaki H, Kondo T, Tatsumi G, Kotani S, Arai Y, Shirakawa K, Kitano T, Hishizawa M, Kadowaki N, Takaori-Kondo A	Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome.	Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome.	Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome.	[Rinsho ketsueki] The Japanese journal of clinical hematology, 56, 3, 312-316	[Rinsho ketsueki] The Japanese journal of clinical hematology, 56, 3, 312-316	[Rinsho ketsueki] The Japanese journal of clinical hematology, 56, 3, 312-316	2015	Refereed			Disclose to all
Shirakawa K, Chavez L, Hakre S, Calvanese V, Verdin E	Shirakawa K, Chavez L, Hakre S, Calvanese V, Verdin E	Shirakawa K, Chavez L, Hakre S, Calvanese V, Verdin E	Reactivation of latent HIV by histone deacetylase inhibitors.	Reactivation of latent HIV by histone deacetylase inhibitors.	Reactivation of latent HIV by histone deacetylase inhibitors.	Trends in microbiology, 21, 6, 277-285	Trends in microbiology, 21, 6, 277-285	Trends in microbiology, 21, 6, 277-285	2013/06	Refereed			Disclose to all
Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RV Jr, de Cabo R, Ulrich S, Akassoglou K, Verdin E	Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RV Jr, de Cabo R, Ulrich S, Akassoglou K, Verdin E	Shimazu T, Hirschey MD, Newman J, He W, Shirakawa K, Le Moan N, Grueter CA, Lim H, Saunders LR, Stevens RD, Newgard CB, Farese RV Jr, de Cabo R, Ulrich S, Akassoglou K, Verdin E	Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.	Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.	Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor.	Science (New York, N.Y.), 339, 6116, 211-214	Science (New York, N.Y.), 339, 6116, 211-214	Science (New York, N.Y.), 339, 6116, 211-214	2013/01	Refereed			Disclose to all
Spina CA, Anderson J, Archin NM, Bosque A, Chan J, Famiglietti M, Greene WC, Kashuba A, Lewin SR, Margolis DM, Mau M, Ruelas D, Saleh S, Shirakawa K, Siliciano RF, Singhania A, Soto PC, Terry VH, Verdin E, Woelk C, Wooden S, Xing S, Planelles V	Spina CA, Anderson J, Archin NM, Bosque A, Chan J, Famiglietti M, Greene WC, Kashuba A, Lewin SR, Margolis DM, Mau M, Ruelas D, Saleh S, Shirakawa K, Siliciano RF, Singhania A, Soto PC, Terry VH, Verdin E, Woelk C, Wooden S, Xing S, Planelles V	Spina CA, Anderson J, Archin NM, Bosque A, Chan J, Famiglietti M, Greene WC, Kashuba A, Lewin SR, Margolis DM, Mau M, Ruelas D, Saleh S, Shirakawa K, Siliciano RF, Singhania A, Soto PC, Terry VH, Verdin E, Woelk C, Wooden S, Xing S, Planelles V	An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients.	An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients.	An in-depth comparison of latent HIV-1 reactivation in multiple cell model systems and resting CD4+ T cells from aviremic patients.	PLoS pathogens, 9, 12, e1003834	PLoS pathogens, 9, 12, e1003834	PLoS pathogens, 9, 12, e1003834	2013	Refereed			Disclose to all
Hakre S, Chavez L, Shirakawa K, Verdin E	Hakre S, Chavez L, Shirakawa K, Verdin E	Hakre S, Chavez L, Shirakawa K, Verdin E	HIV latency: experimental systems and molecular models.	HIV latency: experimental systems and molecular models.	HIV latency: experimental systems and molecular models.	FEMS microbiology reviews, 36, 3, 706-716	FEMS microbiology reviews, 36, 3, 706-716	FEMS microbiology reviews, 36, 3, 706-716	2012/05	Refereed			Disclose to all
Hakre S, Chavez L, Shirakawa K, Verdin E	Hakre S, Chavez L, Shirakawa K, Verdin E	Hakre S, Chavez L, Shirakawa K, Verdin E	Epigenetic regulation of HIV latency.	Epigenetic regulation of HIV latency.	Epigenetic regulation of HIV latency.	Current opinion in HIV and AIDS, 6, 1, 19-24	Current opinion in HIV and AIDS, 6, 1, 19-24	Current opinion in HIV and AIDS, 6, 1, 19-24	2011/01	Refereed			Disclose to all
Izumi T, Io K, Matsui M, Shirakawa K, Shinohara M, Nagai Y, Kawahara M, Kobayashi M, Kondoh H, Misawa N, Koyanagi Y, Uchiyama T, Takaori-Kondo A	Izumi T, Io K, Matsui M, Shirakawa K, Shinohara M, Nagai Y, Kawahara M, Kobayashi M, Kondoh H, Misawa N, Koyanagi Y, Uchiyama T, Takaori-Kondo A	Izumi T, Io K, Matsui M, Shirakawa K, Shinohara M, Nagai Y, Kawahara M, Kobayashi M, Kondoh H, Misawa N, Koyanagi Y, Uchiyama T, Takaori-Kondo A	HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication.	HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication.	HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replication.	Proceedings of the National Academy of Sciences of the United States of America, 107, 48, 20798-20803	Proceedings of the National Academy of Sciences of the United States of America, 107, 48, 20798-20803	Proceedings of the National Academy of Sciences of the United States of America, 107, 48, 20798-20803	2010/11	Refereed			Disclose to all
Izumi T, Takaori-Kondo A, Shirakawa K, Higashitsuji H, Itoh K, Io K, Matsui M, Iwai K, Kondoh H, Sato T, Tomonaga M, Ikeda S, Akari H, Koyanagi Y, Fujita J, Uchiyama T	Izumi T, Takaori-Kondo A, Shirakawa K, Higashitsuji H, Itoh K, Io K, Matsui M, Iwai K, Kondoh H, Sato T, Tomonaga M, Ikeda S, Akari H, Koyanagi Y, Fujita J, Uchiyama T	Izumi T, Takaori-Kondo A, Shirakawa K, Higashitsuji H, Itoh K, Io K, Matsui M, Iwai K, Kondoh H, Sato T, Tomonaga M, Ikeda S, Akari H, Koyanagi Y, Fujita J, Uchiyama T	MDM2 is a novel E3 ligase for HIV-1 Vif.	MDM2 is a novel E3 ligase for HIV-1 Vif.	MDM2 is a novel E3 ligase for HIV-1 Vif.	Retrovirology, 6, 1	Retrovirology, 6, 1	Retrovirology, 6, 1	2009/01	Refereed			Disclose to all
Kotaro SirakawaShirakawa K, Takaori-Kondo A, Yokoyama M, Izumi T, Matsui M, Io K, Sato T, Sato H, Uchiyama T.	Shirakawa K, Takaori-Kondo A, Yokoyama M, Izumi T, Matsui M, Io K, Sato T, Sato H, Uchiyama T.	Kotaro SirakawaShirakawa K, Takaori-Kondo A, Yokoyama M, Izumi T, Matsui M, Io K, Sato T, Sato H, Uchiyama T.	Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif.	Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif.	Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif.	Nat Struct Mol Biol., 15, 11, 1184-1191	Nat Struct Mol Biol., 15, 11, 1184-1191	Nat Struct Mol Biol., 15, 11, 1184-1191	2008/11	Refereed	English	Research paper(scientific journal)	Disclose to all
Izumi T, Shirakawa K, Takaori-Kondo A.	Izumi T, Shirakawa K, Takaori-Kondo A.	Izumi T, Shirakawa K, Takaori-Kondo A.	Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy.	Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy.	Cytidine deaminases as a weapon against retroviruses and a new target for antiviral therapy.	Mini Rev Med Chem., 8, 3, 231-238	Mini Rev Med Chem., 8, 3, 231-238	Mini Rev Med Chem., 8, 3, 231-238	2008/03	Refereed	English	Research paper(scientific journal)	Disclose to all
Noguchi C, Hiraga N, Mori N, Tsuge M, Imamura M, Takahashi S, Fujimoto Y, Ochi H, Abe H, Maekawa T, Yatsuji H, Shirakawa K, Takaori-Kondo A, Chayama K.	Noguchi C, Hiraga N, Mori N, Tsuge M, Imamura M, Takahashi S, Fujimoto Y, Ochi H, Abe H, Maekawa T, Yatsuji H, Shirakawa K, Takaori-Kondo A, Chayama K.	Noguchi C, Hiraga N, Mori N, Tsuge M, Imamura M, Takahashi S, Fujimoto Y, Ochi H, Abe H, Maekawa T, Yatsuji H, Shirakawa K, Takaori-Kondo A, Chayama K.	Dual effect of APOBEC3G on Hepatitis B virus.	Dual effect of APOBEC3G on Hepatitis B virus.	Dual effect of APOBEC3G on Hepatitis B virus.	J Gen Virol., 88, 2, 432-440	J Gen Virol., 88, 2, 432-440	J Gen Virol., 88, 2, 432-440	2007/02	Refereed	English	Research paper(scientific journal)	Disclose to all
Abudu A, Takaori-Kondo A, Izumi T, Shirakawa K, Kobayashi M, Sasada A, Fukunaga K, Uchiyama T.	Abudu A, Takaori-Kondo A, Izumi T, Shirakawa K, Kobayashi M, Sasada A, Fukunaga K, Uchiyama T.	Abudu A, Takaori-Kondo A, Izumi T, Shirakawa K, Kobayashi M, Sasada A, Fukunaga K, Uchiyama T.	Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms.	Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms.	Murine retrovirus escapes from murine APOBEC3 via two distinct novel mechanisms.	Curr Biol., 16, 15, 1565-1570	Curr Biol., 16, 15, 1565-1570	Curr Biol., 16, 15, 1565-1570	2006/08	Refereed	English	Research paper(scientific journal)	Disclose to all
Shirakawa K, Takaori-Kondo A, Kobayashi M, Tomonaga M, Izumi T, Fukunaga K, Sasada A, Abudu A, Miyauchi Y, Akari H, Iwai K, Uchiyama T.	Shirakawa K, Takaori-Kondo A, Kobayashi M, Tomonaga M, Izumi T, Fukunaga K, Sasada A, Abudu A, Miyauchi Y, Akari H, Iwai K, Uchiyama T.	Shirakawa K, Takaori-Kondo A, Kobayashi M, Tomonaga M, Izumi T, Fukunaga K, Sasada A, Abudu A, Miyauchi Y, Akari H, Iwai K, Uchiyama T.	Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.	Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.	Ubiquitination of APOBEC3 proteins by the Vif-Cullin5-ElonginB-ElonginC complex.	Virology., 344, 2, 263-266	Virology., 344, 2, 263-266	Virology., 344, 2, 263-266	2006/01	Refereed	English	Research paper(scientific journal)	Disclose to all
Sasada A, Takaori-Kondo A, Shirakawa K, Kobayashi M, Abudu A, Hishizawa M, Imada K, Tanaka Y, Uchiyama T.	Sasada A, Takaori-Kondo A, Shirakawa K, Kobayashi M, Abudu A, Hishizawa M, Imada K, Tanaka Y, Uchiyama T.	Sasada A, Takaori-Kondo A, Shirakawa K, Kobayashi M, Abudu A, Hishizawa M, Imada K, Tanaka Y, Uchiyama T.	APOBEC3G targets human T-cell leukemia virus type 1.	APOBEC3G targets human T-cell leukemia virus type 1.	APOBEC3G targets human T-cell leukemia virus type 1.	Retrovirology., 19, 2, 32	Retrovirology., 19, 2, 32	Retrovirology., 19, 2, 32	2005/05	Refereed	English	Research paper(scientific journal)	Disclose to all
Wake A, Shirakawa K, Kamio M, Yamasaki Y, Sawada H, Izumi Y.	Wake A, Shirakawa K, Kamio M, Yamasaki Y, Sawada H, Izumi Y.	Wake A, Shirakawa K, Kamio M, Yamasaki Y, Sawada H, Izumi Y.	[Analyses of the allogeneic stem cell transplantation outcome based on the new risk classification].	[Analyses of the allogeneic stem cell transplantation outcome based on the new risk classification].	[Analyses of the allogeneic stem cell transplantation outcome based on the new risk classification].	Rinsho Ketsueki., 45, 1, 48-56	Rinsho Ketsueki., 45, 1, 48-56	Rinsho Ketsueki., 45, 1, 48-56	2004/01	Refereed	English	Research paper(scientific journal)	Disclose to all
<< < > >> Title language:

Misc

Author	Author(Japanese)	Author(English)	Title	Title(Japanese)	Title(English)	Bibliography	Bibliography(Japanese)	Bibliography(English)	Publication date	Language	Disclose
白川康太郎	白川康太郎	白川康太郎	HDACiによるshock and kill	HDACiによるshock and kill	HDACiによるshock and kill	日本エイズ学会誌, 18, 4, 351	日本エイズ学会誌, 18, 4, 351	日本エイズ学会誌, 18, 4, 351	2016/11/20	Japanese	Disclose to all
永田佳代子, 新堂啓祐, 松井佑亮, 白川康太郎, 高折晃史	永田佳代子, 新堂啓祐, 松井佑亮, 白川康太郎, 高折晃史	永田佳代子, 新堂啓祐, 松井佑亮, 白川康太郎, 高折晃史	PPP2R5DはVifユビキチンリガーゼの基質であり,Vifの誘導する細胞周期停止に関わっている	PPP2R5DはVifユビキチンリガーゼの基質であり,Vifの誘導する細胞周期停止に関わっている	PPP2R5DはVifユビキチンリガーゼの基質であり,Vifの誘導する細胞周期停止に関わっている	日本エイズ学会誌, 18, 4, 487	日本エイズ学会誌, 18, 4, 487	日本エイズ学会誌, 18, 4, 487	2016/11/20	Japanese	Disclose to all
吉永則良, 白川康太郎, 福田寛文, 新堂啓祐, 小林正行, 高折晃史	吉永則良, 白川康太郎, 福田寛文, 新堂啓祐, 小林正行, 高折晃史	吉永則良, 白川康太郎, 福田寛文, 新堂啓祐, 小林正行, 高折晃史	リンパ腫合併症例に対する自家末梢血幹細胞移植のHIV‐1プロウイルス量および潜伏感染リザーバーサイズへの影響	リンパ腫合併症例に対する自家末梢血幹細胞移植のHIV‐1プロウイルス量および潜伏感染リザーバーサイズへの影響	リンパ腫合併症例に対する自家末梢血幹細胞移植のHIV‐1プロウイルス量および潜伏感染リザーバーサイズへの影響	日本エイズ学会誌, 18, 4, 492	日本エイズ学会誌, 18, 4, 492	日本エイズ学会誌, 18, 4, 492	2016/11/20	Japanese	Disclose to all
福田寛文, SARCA Daniela, 山下和男, LI Songling, STANDLEY Daron, LI Songling, STANDLEY Daron, 白川康太郎, 高折晃史, 泉泰輔	福田寛文, SARCA Daniela, 山下和男, LI Songling, STANDLEY Daron, LI Songling, STANDLEY Daron, 白川康太郎, 高折晃史, 泉泰輔	福田寛文, SARCA Daniela, 山下和男, LI Songling, STANDLEY Daron, LI Songling, STANDLEY Daron, 白川康太郎, 高折晃史, 泉泰輔	APOBEC3GのN末端ドメインの構造的洞察による,RNA結合に重要なアミノ酸残基の同定	APOBEC3GのN末端ドメインの構造的洞察による,RNA結合に重要なアミノ酸残基の同定	APOBEC3GのN末端ドメインの構造的洞察による,RNA結合に重要なアミノ酸残基の同定	日本エイズ学会誌, 18, 4, 487	日本エイズ学会誌, 18, 4, 487	日本エイズ学会誌, 18, 4, 487	2016/11/20	Japanese	Disclose to all
大塚泰幸, 白川康太郎, 錦織桃子, 菱澤方勝, 北野俊行, 羽賀博典, 高折晃史	大塚泰幸, 白川康太郎, 錦織桃子, 菱澤方勝, 北野俊行, 羽賀博典, 高折晃史	大塚泰幸, 白川康太郎, 錦織桃子, 菱澤方勝, 北野俊行, 羽賀博典, 高折晃史	極めて急速な臨床経過をたどったcMYC/IGH,BCL2/IGH,PAX5/IGH転座を有するtriple‐hit lymphomaの一例	極めて急速な臨床経過をたどったcMYC/IGH,BCL2/IGH,PAX5/IGH転座を有するtriple‐hit lymphomaの一例	極めて急速な臨床経過をたどったcMYC/IGH,BCL2/IGH,PAX5/IGH転座を有するtriple‐hit lymphomaの一例	日本リンパ網内系学会会誌, 56, 95	日本リンパ網内系学会会誌, 56, 95	日本リンパ網内系学会会誌, 56, 95	2016/08/05	Japanese	Disclose to all
白川康太郎	白川康太郎	白川康太郎	βヒドロキシ酪酸による酸化ストレス制御と疾患	βヒドロキシ酪酸による酸化ストレス制御と疾患	βヒドロキシ酪酸による酸化ストレス制御と疾患	日本抗加齢医学会総会プログラム・抄録集, 16th, 81	日本抗加齢医学会総会プログラム・抄録集, 16th, 81	日本抗加齢医学会総会プログラム・抄録集, 16th, 81	2016	Japanese	Disclose to all
島津忠広, 白川康太郎, VERDIN Eric	島津忠広, 白川康太郎, VERDIN Eric	島津忠広, 白川康太郎, VERDIN Eric	βヒドロキシ酪酸は内在性のHDAC阻害剤として酸化ストレス抑制に関わる	βヒドロキシ酪酸は内在性のHDAC阻害剤として酸化ストレス抑制に関わる	βヒドロキシ酪酸は内在性のHDAC阻害剤として酸化ストレス抑制に関わる	日本薬学会年会要旨集(CD-ROM), 136th, ROMBUNNO.S37‐2	日本薬学会年会要旨集(CD-ROM), 136th, ROMBUNNO.S37‐2	日本薬学会年会要旨集(CD-ROM), 136th, ROMBUNNO.S37‐2	2016	Japanese	Disclose to all
松井佑亮, 新堂啓祐, 小林正行, 白川康太郎, 近藤忠一, 高折晃史	松井佑亮, 新堂啓祐, 小林正行, 白川康太郎, 近藤忠一, 高折晃史	松井佑亮, 新堂啓祐, 小林正行, 白川康太郎, 近藤忠一, 高折晃史	Picture in Clinical Hematology No. 96	Picture in Clinical Hematology No. 96	Picture in Clinical Hematology No. 96	臨床血液, 57, 8, 985(J‐STAGE)	臨床血液, 57, 8, 985(J‐STAGE)	臨床血液, 57, 8, 985(J‐STAGE)	2016	Japanese	Disclose to all
福田寛文, 松井佑亮, 白川康太郎, 和田典也, 宮川敬, 梁明秀, 高折晃史	福田寛文, 松井佑亮, 白川康太郎, 和田典也, 宮川敬, 梁明秀, 高折晃史	福田寛文, 松井佑亮, 白川康太郎, 和田典也, 宮川敬, 梁明秀, 高折晃史	APOBEC3Gのアセチル化修飾と機能調節	APOBEC3Gのアセチル化修飾と機能調節	APOBEC3Gのアセチル化修飾と機能調節	日本エイズ学会誌, 17, 4, 374	日本エイズ学会誌, 17, 4, 374	日本エイズ学会誌, 17, 4, 374	2015/11/20	Japanese	Disclose to all
永田佳代子, 新堂啓祐, 松井佑亮, 白川康太郎, 小林正行, 高折晃史	永田佳代子, 新堂啓祐, 松井佑亮, 白川康太郎, 小林正行, 高折晃史	永田佳代子, 新堂啓祐, 松井佑亮, 白川康太郎, 小林正行, 高折晃史	Vifの誘導する細胞周期G2停止機構の探求	Vifの誘導する細胞周期G2停止機構の探求	Vifの誘導する細胞周期G2停止機構の探求	日本エイズ学会誌, 17, 4, 375	日本エイズ学会誌, 17, 4, 375	日本エイズ学会誌, 17, 4, 375	2015/11/20	Japanese	Disclose to all
YAMAZAKI HIROYUKI, KONDO TADAKAZU, TATSUMI GOICHI, KOTANI SHIN'ICHI, ARAI YASUYUKI, SHIRAKAWA KOTARO, KITANO TOSHIYUKI, HISHIZAWA MASAKATSU, KADOWAKI NORIMITSU, TAKAORI AKIFUMI	山崎寛章, 近藤忠一, 辰巳剛一, 小谷槙一, 新井康之, 白川康太郎, 北野俊行, 菱澤方勝, 門脇則光, 高折晃史	YAMAZAKI HIROYUKI, KONDO TADAKAZU, TATSUMI GOICHI, KOTANI SHIN'ICHI, ARAI YASUYUKI, SHIRAKAWA KOTARO, KITANO TOSHIYUKI, HISHIZAWA MASAKATSU, KADOWAKI NORIMITSU, TAKAORI AKIFUMI	Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome	遺伝子組み換え型ヒトトロンボモジュリン製剤が有効であった血球貪食症候群併発播種性血管内凝固	Successful treatment with recombinant thrombomodulin for disseminated intravascular coagulation complicated with hemophagocytic syndrome	臨床血液, 56, 3, 312-316 (J-STAGE)	臨床血液, 56, 3, 312-316 (J-STAGE)	臨床血液, 56, 3, 312-316 (J-STAGE)	2015	Japanese	Disclose to all
SHIRAKAWA KOTARO	白川康太郎	SHIRAKAWA KOTARO	HIV潜伏感染細胞の研究の最前線	HIV潜伏感染細胞の研究の最前線	HIV潜伏感染細胞の研究の最前線	日本エイズ学会誌, 16, 4, 340	日本エイズ学会誌, 16, 4, 340	日本エイズ学会誌, 16, 4, 340	2014/11/20	Japanese	Disclose to all
MATSUI YUSUKE, SHINDO KEISUKE, NAGATA KAYOKO, YOSHINAGA NORIYOSHI, MARUYAMA WATARU, SHIRAKAWA KOTARO, KOBAYASHI MASAYUKI, TAKAORI AKIFUMI	松井佑亮, 新堂啓祐, 永田佳代子, 吉永則良, 丸山亙, 白川康太郎, 小林正行, 高折晃史	MATSUI YUSUKE, SHINDO KEISUKE, NAGATA KAYOKO, YOSHINAGA NORIYOSHI, MARUYAMA WATARU, SHIRAKAWA KOTARO, KOBAYASHI MASAYUKI, TAKAORI AKIFUMI	CBFβはMDM2によるVifの分解を阻害することでVifを安定化する	CBFβはMDM2によるVifの分解を阻害することでVifを安定化する	CBFβはMDM2によるVifの分解を阻害することでVifを安定化する	日本エイズ学会誌, 16, 4, 442	日本エイズ学会誌, 16, 4, 442	日本エイズ学会誌, 16, 4, 442	2014/11/20	Japanese	Disclose to all
SHIRAKAWA KOTARO, TAKAORI AKIFUMI	白川康太郎, 高折晃史	SHIRAKAWA KOTARO, TAKAORI AKIFUMI	HIVの潜伏感染とその根絶への仮説的戦略	HIVの潜伏感染とその根絶への仮説的戦略	HIVの潜伏感染とその根絶への仮説的戦略	HIV感染症とAIDSの治療, 5, 1, 21-27	HIV感染症とAIDSの治療, 5, 1, 21-27	HIV感染症とAIDSの治療, 5, 1, 21-27	2014/05/20	Japanese	Disclose to all
SHIRAKAWA KOTARO	白川康太郎	SHIRAKAWA KOTARO	HIV感染症2013~現状と展望~3.潜伏感染とそれを標的とした新規治療について	HIV感染症2013~現状と展望~3.潜伏感染とそれを標的とした新規治療について	HIV感染症2013~現状と展望~3.潜伏感染とそれを標的とした新規治療について	血液フロンティア, 23, 6, 773-781	血液フロンティア, 23, 6, 773-781	血液フロンティア, 23, 6, 773-781	2013/05/30	Japanese	Disclose to all
IZUMI YASUSUKE, SHIRAKAWA KOTARO, MATSUI MASASHI, IO KATSUHIRO, SHINOHARA MASANOBU, UCHIYAMA TAKASHI, TAKAORI AKIFUMI	泉泰輔, 白川康太郎, 松井道志, 井尾克宏, 篠原正信, 内山卓, 高折晃史	IZUMI YASUSUKE, SHIRAKAWA KOTARO, MATSUI MASASHI, IO KATSUHIRO, SHINOHARA MASANOBU, UCHIYAMA TAKASHI, TAKAORI AKIFUMI	HIV‐1Vifはp53を介してその機能を発揮する	HIV‐1Vifはp53を介してその機能を発揮する	HIV‐1Vifはp53を介してその機能を発揮する	日本エイズ学会誌, 11, 4, 601	日本エイズ学会誌, 11, 4, 601	日本エイズ学会誌, 11, 4, 601	2009/11/20	Japanese	Disclose to all
IZUMI TAISUKE, SHIRAKAWA KOTARO, MATSUI MASASHI, IO KATSUHIRO, SHINOHARA MASANOBU, UCHIYAMA TAKASHI, TAKAORI AKIFUMI	泉泰輔, 白川康太郎, 松井道志, 井尾克宏, 篠原正信, 内山卓, 高折晃史	IZUMI TAISUKE, SHIRAKAWA KOTARO, MATSUI MASASHI, IO KATSUHIRO, SHINOHARA MASANOBU, UCHIYAMA TAKASHI, TAKAORI AKIFUMI	HIV‐1 Vifはp53を介してその機能を発揮する	HIV‐1 Vifはp53を介してその機能を発揮する	HIV‐1 Vifはp53を介してその機能を発揮する	日本ウイルス学会学術集会プログラム・抄録集, 57th, 156	日本ウイルス学会学術集会プログラム・抄録集, 57th, 156	日本ウイルス学会学術集会プログラム・抄録集, 57th, 156	2009/10/01	Japanese	Disclose to all
IZUMI TAISUKE, TAKAORI KOJI, SHIRAKAWA KOTARO, MATSUI MICHISHI, IO KATSUHIRO, UCHIYAMA TAKASHI	泉泰輔, 高折晃史, 白川康太郎, 松井道志, 井尾克宏, 内山卓	IZUMI TAISUKE, TAKAORI KOJI, SHIRAKAWA KOTARO, MATSUI MICHISHI, IO KATSUHIRO, UCHIYAMA TAKASHI	HIV‐1 Vifはp53依存的経路で感染細胞の細胞周期をG2/M期に停止させる	HIV‐1 Vifはp53依存的経路で感染細胞の細胞周期をG2/M期に停止させる	HIV‐1 Vifはp53依存的経路で感染細胞の細胞周期をG2/M期に停止させる	日本エイズ学会誌, 10, 4, 470	日本エイズ学会誌, 10, 4, 470	日本エイズ学会誌, 10, 4, 470	2008/11/20	Japanese	Disclose to all
SHIRAKAWA KOTARO, TAKAORI KOJI, YOKOYAMA MASARU, MATSUI MICHISHI, IO KATSUHIRO, IZUMI TAISUKE, SATO HIRONORI, UCHIYAMA TAKASHI	白川康太郎, 高折晃史, 横山勝, 松井道志, 井尾克宏, 泉泰輔, 佐藤裕徳, 内山卓	SHIRAKAWA KOTARO, TAKAORI KOJI, YOKOYAMA MASARU, MATSUI MICHISHI, IO KATSUHIRO, IZUMI TAISUKE, SATO HIRONORI, UCHIYAMA TAKASHI	Protein Kinase Aによるリン酸化はAPOBEC3GとVifの相互作用を調節する	Protein Kinase Aによるリン酸化はAPOBEC3GとVifの相互作用を調節する	Protein Kinase Aによるリン酸化はAPOBEC3GとVifの相互作用を調節する	日本エイズ学会誌, 10, 4, 429	日本エイズ学会誌, 10, 4, 429	日本エイズ学会誌, 10, 4, 429	2008/11/20	Japanese	Disclose to all
YOKOYAMA MASARU, SHIRAKAWA KOTARO, TAKAORI KOJI, SATO HIRONORI	横山勝, 白川康太郎, 高折晃史, 佐藤裕徳	YOKOYAMA MASARU, SHIRAKAWA KOTARO, TAKAORI KOJI, SATO HIRONORI	分子モデリングによるリン酸化APOBEC3Gの構造解析	分子モデリングによるリン酸化APOBEC3Gの構造解析	分子モデリングによるリン酸化APOBEC3Gの構造解析	日本エイズ学会誌, 10, 4, 503	日本エイズ学会誌, 10, 4, 503	日本エイズ学会誌, 10, 4, 503	2008/11/20	Japanese	Disclose to all
<< < > >> Title language:

Awards

Title(Japanese)	Title(English)	Organization name(Japanese)	Organization name(English)	Date
京都大学医学部若手研究者優秀論文賞「KMYIA」	Young Inevstigator Award	京都大学大学院医学研究科	Graduate School of Medicine, Kyoto Unversity	2010/05/02

External funds: competitive funds and Grants-in-Aid for Scientific Research (Kakenhi)

Type	Position	Title(Japanese)	Period
基盤研究(C)	Representative	HIV-1感染症におけるA3Gのアセチル化とVif/HDAC3複合体の役割（平成28年度分）	2016/04/01-2017/03/31
基盤研究(C)	Representative	HIV-1感染症におけるA3Gのアセチル化とVif/HDAC3複合体の役割（平成29年度分）	2017/04/01-2018/03/31
平成３０年度　基盤研究（Ａ）	Assignment	新規技術による白血病の包括的エンハンサー解析と分子病態解明	2018/04/01-2022/03/31
基盤研究(C)	Representative	HIV-1感染症におけるA3Gのアセチル化とVif/HDAC3複合体の役割（平成30年度分）	2018/04/01-2019/03/31
基盤研究（C）	Representative	HIV-1Vif/HDAC3複合体によるHIV-1潜伏感染転写ネットワークの制御	2019/04/01-2020/03/31

白川 康太郎

白川康太郎